Subscribe

MariMed Inc. (MRMD)

USD0.07 +0.00 (+0.38%)
US OTC Healthcare Drug Manufacturers - Specialty & Generic
Address 10 Oceana Way 2062
Norwood, MA, US
CEO Jon R. Levine
IPO 2012-08-03
CIK 1522767 ISIN US56782V1070

Explore sections of this company profile

Also trades on Canadian Securities Exchange · MRMD.CN (CAD) Other OTC · MRMD (USD)
Description

MariMed Inc. operates in the cannabis industry, specializing in the cultivation, production, and sale of both medicinal and adult-use cannabis items throughout the United States and internationally. The company's diverse product portfolio includes cannabis flowers and concentrates marketed under the Nature's Heritage brand. It also offers infused goods such as chewable tablets and powdered drink mixes under the Kalm Fusion label, natural fruit chews known as Betty's Eddies, and a line of baked treats like brownies and cookies available through Bubby's Baked. Furthermore, MariMed develops cannabidiol (CBD) products under the Florance brand. Beyond its own offerings, the company licenses its various brands and product formulations to others and leases facilities designed for cannabis operations. MariMed Inc., founded in 2011, is based in Norwood, Massachusetts.

News Sentiment (7d)
Market Cap & Enterprise Value
Merger & Acquisition History

No mergers or acquisitions recorded for this company.

Technical Outlook
Loading outlook…
Loading forecast...
Signal Summary Loading…
Indicator 1D1W2W3W1M
Each column is computed on that timeframe's candles (1D = daily, 1W ≈ weekly, 1M ≈ monthly), not on the same last day. ▲ bullish · ▼ bearish · — neutral. The Net row counts signals per column; hover any cell (or the indicator name) to see the exact rule behind it.
Day Score & sub-scores
Statistical fingerprint & regime detail
Conditional historical analysis
Customize analysis (advanced)
Indicative levels generated algorithmically. Not financial advice.
Risk Profile
Loading risk profile…
Price Chart
Averages
Trend
Price
Levels
Draw
USD0.07 +0.00 (+0.38%)
Loading historical data…
Volume Profile
Loading…
Liquidity & share structure
Average Volume
703.6K
Beta
1.33
Float Shares
331.82M
Free Float %
83.2%
Price Performance
1D5D1M3M6M YTD1Y3Y5Y10YMax
+1.92% -0.24% +21.32% -3.31% -5.90% -3.53% -0.24% -82.69% -88.69% -39.39% +41.33%
Rolling Volatility
Loading…
Drawdown
Loading…
Relative Strength
Loading…
Monthly Returns Heatmap
From To
Loading…
Annual Monthly Returns
Loading…
Daily Returns Distribution
vs.
Loading histogram data…

Revenue flow

Revenue by geography

Revenue by segment

From To

Revenue composition

From To

By product

By geography

Financial Statements

Income Statement

Balance Sheet

Cash Flow Statement

Key Metrics

Financial Ratios

Employees

Financial Growth (CAGR)

Market Data

Analyst Consensus (1 ratings, all time) Buy
Price Targets & DCF
Current price
0.07
Low 2.25 +3,288.6%
Consensus 2.25 +3,288.6%
Median 2.25 +3,288.6%
High 2.25 +3,288.6%
DCF (Unlevered) 0.66 +894.1%

DCF figures are point estimates: small changes in growth or discount-rate assumptions move them materially. Read them as a reference, not a precise target.

Ratings Trend (MoM) 100% Bullish
Rating 2026-05 Change
Strong Buy 0 0
Buy 2 0
Hold 0 0
Sell 0 0
Strong Sell 0 0
Price Target Summary
Period # Analysts Avg Target
Last Month
Last Quarter
Last Year
All Time 1
2.25
+3,288.6%
Quality scores
Altman Z-Score
0.01
Distress
Piotroski F-Score
3 / 9
Average
MOAT Score
1 / 10
No MOAT
Composite Rating
C+
Overall Score
2 / 5
Medium
DCF Score
4 / 5
High
ROE Score
1 / 5
Low
ROA Score
1 / 5
Low
D/E Score
1 / 5
Low
P/E Score
1 / 5
Low
P/Book Score
5 / 5
High
Operational MOAT
✗ Below peers
  • Revenue growth Drug Manufacturers - Specialty & Generic: +6.8%
    +1.2% Q1'26: +4.0% (vs Q1'25)
  • EPS growth Drug Manufacturers - Specialty & Generic: +16.5%
    -15.6% Q1'26: +30.1% (vs Q1'25)
  • FCF margin FCF growth · Drug Manufacturers - Specialty & Generic: +32.3%
    +1.9% Q1'26: +1.5% (vs Q1'25)
  • EBIT margin Drug Manufacturers - Specialty & Generic: +13.0%
    -1.3% Q1'26: +0.0% (vs Q1'25)
  • ROIC Drug Manufacturers - Specialty & Generic: +6.5%
    -1.5% Q1'26: +0.0% (vs Q1'25)
  • Share dilution Drug Manufacturers - Specialty & Generic: +0.0%
    +2.9% Q1'26: +3.9% (vs Q1'25)
  • Debt / EBITDA Net debt/EBITDA · Drug Manufacturers - Specialty & Generic: -0.10×
    10.60× Q1'26: 182.42× (vs Q1'25)
Valuation Multiples From To
Price Forecast (3Y) From To
Model
Adjust
P/E
Theoretical Return — If Invested Today

* These projections are based on analyst consensus estimates and user-defined valuation multiples. This table is for informational purposes only and does not constitute a recommendation to buy or sell any security. Past performance is not indicative of future results.

DCF Interactive Model (UFCF)
Projection years:
Market assumptions
WACC components (optional)
Ke (Cost of Equity) = Rf + β (1.34) × ERP
WACC = 25% × Ke + 75% × Kd (7.5%) × (1−t)

Modifying these values recalculates WACC automatically.

Business assumptions
Intrinsic value (base): 0.66 Current price: 0.07
Enterprise Value: Equity Value: Terminal Value: TV as % of EV:

Base values reflect the latest available data for this company and market conditions.

Consensus Estimates
Metric Dec 2021
actual
Dec 2022
actual
Dec 2023
actual
Dec 2024
actual
Dec 2025
actual
Dec 2026
1 Rev. Ana.
1 EPS Ana.
Dec 2027
1 Rev. Ana.
1 EPS Ana.
Dec 2028
1 Rev. Ana.
1 EPS Ana.
Revenue
121.46M
est: 119.25M (+1.9%)
134.01M
est: 133.29M (+0.5%)
148.60M
est: 156.07M (-4.8%)
157.96M
est: 160.86M (-1.8%)
159.83M
est: 161.55M (-1.1%)
162.15M
161.20M – 163.10M
+0.4% YoY
171.70M
170.69M – 172.71M
+5.9% YoY
171.70M
170.69M – 172.71M
+0.0% YoY
EBITDA
28.96M
est: 21.90M (+32.2%)
25.92M
est: 24.48M (+5.8%)
11.16M
est: 20.40M (-45.3%)
13.83M
est: 21.03M (-34.2%)
9.44M
est: 21.12M (-55.3%)
21.20M
21.07M – 21.32M
+0.4% YoY
22.44M
22.31M – 22.58M
+5.9% YoY
22.44M
22.31M – 22.58M
+0.0% YoY
EBIT
26.17M
est: 16.48M (+58.8%)
21.20M
est: 18.42M (+15.1%)
2.59M
est: 12.39M (-79.1%)
2.98M
est: 12.77M (-76.7%)
-2.07M
est: 12.83M (-116.1%)
12.87M
12.80M – 12.95M
+0.4% YoY
13.63M
13.55M – 13.71M
+5.9% YoY
13.63M
13.55M – 13.71M
+0.0% YoY
Net Income
7.23M
est: 17.06M (-57.7%)
13.47M
est: 11.37M (+18.4%)
-16.03M
-12.16M
est: -5.85M (-107.9%)
-14.48M
est: -11.70M (-23.8%)
-17.56M
-17.69M – -17.42M
-50.0% YoY
-11.70M
-11.79M – -11.61M
+33.3% YoY
-7.80M
-7.86M – -7.74M
+33.3% YoY
SGA
37.54M
est: 38.82M (-3.3%)
38.88M
est: 43.39M (-10.4%)
50.84M
est: 46.99M (+8.2%)
59.34M
est: 48.43M (+22.5%)
30.12M
est: 48.64M (-38.1%)
48.82M
48.53M – 49.11M
+0.4% YoY
51.69M
51.39M – 52.00M
+5.9% YoY
51.69M
51.39M – 52.00M
+0.0% YoY
EPS
0.02
est: 0.05 (-50.9%)
0.04
est: 0.03 (+33.0%)
-0.04
-0.03
est: -0.02 (-114.0%)
-0.04
est: -0.03 (-23.7%)
-0.05
-0.05 – -0.04
-50.0% YoY
-0.03
-0.03 – -0.03
+33.3% YoY
-0.02
-0.02 – -0.02
+33.3% YoY
Historical Ratings (3M)
Date Rating Overall DCF ROE ROA D/E P/E P/B
2026-05-12 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-05-11 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-05-08 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-05-07 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-05-06 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-05-05 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-05-04 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-05-01 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-04-30 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-04-29 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-04-28 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-04-27 C+ 2/5 4/5 1/5 1/5 1/5 1/5 5/5
2026-04-24 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-23 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-22 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-21 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-20 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-17 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5
2026-04-16 C+ 2/5 4/5 1/5 1/5 1/5 1/5 4/5

Owner Earnings

Owner's Earnings (history) From To
Owner alignment
Owner's Earnings TTM
7.65M
OE per share TTM
0.02
Owner's Yield
22.82%
Maintenance CapEx ratio
Maint CapEx / Avg PPE
67.7%

Ownership Overview

Ownership breakdown
At a glance
Institutional holders
4
Total invested
91.3K
Insider transactions (90d)
1
Beneficial owners (>5%)
0
Beneficial owners (>5%)

No beneficial ownership filings recorded.

Institutional Activity (13F)

Institutional ownership trend From To
13F snapshot — 2025 Q4
Investors holding
4
+0 vs prev Q
New positions
0
Closed positions
0
Increased
0
Reduced
0
Put/Call ratio
0.00
Calls held
Puts held
Top institutional holders
# Investor Shares / Δ Mkt value / Δ Own% / Δ Weight% / Δ Avg px / Perf. Hold / Status
1 CANTON HATHAWAY, LLC 645.1K +— (+0.0%) 44.4K -16.2K (-26.7%) 0.17% +0.001 pp 0.01% -0.003 pp USD0.85 -91.8% 21 qtrs
2 GAME PLAN FINANCIAL ADVISORS, LLC 100.00 +— (+0.0%) 7.00 -2.0 (-22.2%) 0.00% +0.000 pp 0.00% +0.000 pp USD0.27 -74.1% 10 qtrs
Ownership breakdown by holder

ETF Ownership

Top ETFs holding this stock Held by 1 ETFs in our universe
# ETF Weight Est. AUM exposure TER
1 AdvisorShares Pure US Cannabis ETF MSOS 0.03% 284.9K 0.81%

Insider Activity

Insider Activity — Latest Quarter
Ratio by transactions
0.30
Bearish
Ratio by volume
0.14
Bearish
Buys
3
Sells
10
Shares acquired
96.5K
Shares disposed
707.4K
Cash buys
Cash sales
Net activity
-610,939
Insider buys vs sells (history) From To
Recent insider transactions From To
Date Person Role Transaction A/D Security Shares Price Value Owned after D/I Filing
2026-05-07 Levine Jon R Director / Officer / 10% Owner M-Exempt A Common stock 75,000 0.00 21,233,974 D
2026-04-15 Shaw Timothy Officer A-Award D Restricted Stock Units (RSU) 170,625 0.00 170,625 D
2026-04-15 Pinho Mario Officer A-Award D Restricted Stock Units (RSU) 153,125 0.00 153,125 D
2026-04-15 Levine Jon R Director / Officer / 10% Owner A-Award D Restricted Stock Units (RSU) 122,500 0.00 122,500 D
2026-04-15 Crandall Ryan Officer A-Award D Restricted Stock Units (RSU) 131,250 0.00 131,250 D
2026-04-02 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 9,982 0.00 19,963 D
2026-04-02 Levine Jon R Director / Officer / 10% Owner M-Exempt A Common stock 11,518 0.00 21,162,966 D
2026-03-28 Crandall Ryan Officer M-Exempt A Common stock 6,047 0.00 881,730 D
2026-03-07 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 21,667 0.00 0 D
2026-03-07 Levine Jon R Director / Officer / 10% Owner F-InKind D Common stock 8,085 0.08 679.14 21,151,448 D
2026-03-07 Crandall Ryan Officer M-Exempt D Restricted Stock Units (RSU) 12,500 0.00 0 D
2026-03-01 Shaw Timothy Officer M-Exempt A Common stock 65,000 0.00 9,359,541 D
2026-01-15 Pinho Mario Officer M-Exempt A Common stock 49,995 0.00 294,809 D
2025-12-31 Pinho Mario Officer F-InKind D Common stock 15,724 0.09 1.4K 244,814 D
2025-12-15 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 81,772 0.00 0 D
2025-12-15 Selhub Eva M.D. Director A-Award D Restricted Stock Units (RSU) 166,985 0.00 0 D
2025-12-15 Pinho Mario Officer F-InKind D Common stock 4,719 0.11 505.40 206,967 D
2025-12-15 Levine Jon R Director / Officer / 10% Owner M-Exempt D Restricted Stock Units (RSU) 89,859 0.00 0 D
2025-12-15 Gildea Edward J Director M-Exempt D Restricted Stock Units (RSU) 247,385 0.00 0 D
2025-12-15 Crandall Ryan Officer M-Exempt D Restricted Stock Units (RSU) 62,902 0.00 0 D
2025-12-15 Allen David R Director M-Exempt D Restricted Stock Units (RSU) 176,389 0.00 0 D
2025-12-12 Shaw Timothy Officer P-Purchase A Common stock 45,455 0.11 4.9K 9,236,770 D
2025-12-08 Crandall Ryan Officer M-Exempt A Common stock 54,000 0.00 838,925 D
2025-12-05 Selhub Eva M.D. Director A-Award A Restricted Stock Units (RSU) 166,985 0.00 166,985 D
2025-12-05 Gildea Edward J Director A-Award A Restricted Stock Units (RSU) 247,385 0.00 247,385 D
2025-12-05 Allen David R Director A-Award A Restricted Stock Units (RSU) 176,389 0.00 176,389 D
2025-11-29 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 81,250 0.00 162,500 D
2025-11-29 Levine Jon R Director / Officer / 10% Owner M-Exempt D Restricted Stock Units (RSU) 93,750 0.00 187,500 D
2025-11-29 Crandall Ryan Officer M-Exempt D Restricted Stock Units (RSU) 75,000 0.00 150,000 D
2025-11-07 Levine Jon R Director / Officer / 10% Owner M-Exempt A Common stock 75,000 0.00 21,028,494 D
2025-10-27 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 111,112 0.00 0 D
2025-10-27 Levine Jon R Director / Officer / 10% Owner M-Exempt A Common stock 138,888 0.00 20,994,258 D
2025-10-02 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 9,981 0.00 29,945 D
2025-10-02 Levine Jon R Director / Officer / 10% Owner F-InKind D Common stock 3,381 0.16 544.34 20,855,370 D
2025-09-30 Pinho Mario Officer M-Exempt D Restricted Stock Units (RSU) 53,572 0.00 53,571 D
2025-09-28 Crandall Ryan Officer M-Exempt A Common stock 6,046 0.00 733,713 D
2025-09-15 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 81,772 0.00 81,772 D
2025-09-15 Pinho Mario Officer M-Exempt A Common stock 16,076 0.00 161,960 D
2025-09-15 Levine Jon R Director / Officer / 10% Owner M-Exempt D Restricted Stock Units (RSU) 89,860 0.00 89,859 D
2025-09-15 Crandall Ryan Officer M-Exempt D Restricted Stock Units (RSU) 62,901 0.00 62,902 D
2025-09-07 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 21,666 0.00 21,667 D
2025-09-07 Levine Jon R Director / Officer / 10% Owner M-Exempt D Restricted Stock Units (RSU) 23,334 0.00 23,333 D
2025-09-07 Crandall Ryan Officer F-InKind D Common stock 3,669 0.16 570.53 683,228 D
2025-09-01 Shaw Timothy Officer M-Exempt A Common stock 65,000 0.00 8,994,361 D
2025-07-15 Pinho Mario Officer M-Exempt D Restricted Stock Units (RSU) 100,020 0.00 199,980 D
2025-06-30 Pinho Mario Officer M-Exempt D Restricted Stock Units (RSU) 53,571 0.00 107,143 D
2025-06-15 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 81,772 0.00 163,544 D
2025-06-15 Pinho Mario Officer M-Exempt D Restricted Stock Units (RSU) 16,075 0.00 32,171 D
2025-06-15 Levine Jon R Director / Officer / 10% Owner F-InKind D Common stock 31,137 0.07 2.3K 20,767,263 D
2025-06-15 Crandall Ryan Officer M-Exempt D Restricted Stock Units (RSU) 62,902 0.00 125,803 D
2025-06-12 Selhub Eva M.D. Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000 D
2025-06-12 Gildea Edward J Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000 D
2025-06-12 Allen David R Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000 D
2025-06-08 Crandall Ryan Officer M-Exempt D Restricted Stock Units (RSU) 54,000 0.00 108,000 D
2025-06-06 Tucker Kathleen Director M-Exempt A Common stock 75,000 0.00 350,000 D
2025-06-06 Selhub Eva M.D. Director M-Exempt D Restricted Stock Units (RSU) 75,000 0.00 0 D
2025-06-06 Gildea Edward J Director M-Exempt D Restricted Stock Units (RSU) 75,000 0.00 0 D
2025-06-06 Allen David R Director M-Exempt D Restricted Stock Units (RSU) 75,000 0.00 0 D
2025-05-23 Shaw Timothy Officer A-Award A Restricted Stock Units (RSU) 245,316 0.00 245,316 D
2025-05-21 Selhub Eva M.D. Director M-Exempt A Common stock 132,353 0.00 240,686 D
2025-05-21 Gildea Edward J Director M-Exempt D Restricted Stock Units (RSU) 245,099 0.00 0 D
2025-05-21 Allen David R Director M-Exempt D Restricted Stock Units (RSU) 116,422 0.00 0 D
2025-05-15 Selhub Eva M.D. Director A-Award A Restricted Stock Units (RSU) 132,353 0.00 132,353 D
2025-05-15 Gildea Edward J Director A-Award A Restricted Stock Units (RSU) 245,099 0.00 245,099 D
2025-05-15 Allen David R Director A-Award A Restricted Stock Units (RSU) 116,422 0.00 116,422 D
2025-05-09 Pinho Mario Officer A-Award A Restricted Stock Units (RSU) 48,226 0.00 48,246 D
2025-05-09 Levine Jon R Director / Officer / 10% Owner A-Award A Restricted Stock Units (RSU) 269,578 0.00 269,578 D
2025-05-09 Crandall Ryan Officer A-Award A Restricted Stock Units (RSU) 188,705 0.00 188,705 D
2025-05-07 Levine Jon R Director / Officer / 10% Owner M-Exempt A Common stock 75,000 0.00 20,734,529 D
2025-04-27 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 111,111 0.00 111,112 D
2025-04-27 Levine Jon R Director / Officer / 10% Owner F-InKind D Common stock 48,126 0.11 5.2K 20,659,529 D
2025-04-07 Crandall Ryan Officer Restricted Stock Units (RSU) 25,000 0.00 0 D
2025-04-02 Shaw Timothy Officer M-Exempt A Common stock 19,969 0.00 8,810,233 D
2025-04-02 Levine Jon R Director / Officer M-Exempt A Common stock 23,041 0.00 20,576,750 D
2025-03-30 Pinho Mario Officer M-Exempt A Restricted Stock Units (RSU) 53,572 0.00 160,714 D
2025-03-07 Shaw Timothy Officer F-InKind D Common stock 7,508 0.11 824.38 8,790,264 D
2025-03-07 Levine Jon R Director / Officer M-Exempt A Common stock 23,333 0.00 20,561,794 D
2025-03-01 Shaw Timothy Officer M-Exempt A Common stock 65,000 0.00 8,798,628 D
2025-02-18 Pinho Mario Officer A-Award A Restricted Stock Units (RSU) 214,286 0.00 214,286 D
2024-11-29 Shaw Timothy Officer A-Award A Restricted Stock Units (RSU) 243,750 0.00 243,750 D
2024-11-29 Levine Jon R Director / Officer A-Award A Restricted Stock Units (RSU) 281,250 0.00 281,250 D
2024-11-07 Levine Jon R Director / Officer M-Exempt D Restricted Stock Units (RSU) 150,000 0.00 300,000 D
2024-10-27 Shaw Timothy Officer M-Exempt A Common stock 111,111 0.00 8,766,240 D
2024-10-27 Levine Jon R Director / Officer M-Exempt A Common stock 138,889 0.00 20,473,251 D
2024-09-07 Shaw Timothy Officer M-Exempt A Common stock 21,667 0.00 8,661,489
2024-09-07 Levine Jon R Director / Officer M-Exempt A Common stock 23,333 0.00 20,341,211
2024-09-01 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 130,000 0.00 260,000
2024-08-09 Pinho Mario Officer D Restricted Stock Units (RSU) 300,000 0.00 0
2024-06-08 Tucker Kathleen Director M-Exempt D Restricted Stock Units (RSU) 75,000 0.00 0
2024-06-08 Selhub Eva M.D. Director M-Exempt D Restricted Stock Units (RSU) 75,000 0.00 0
2024-06-08 Gildea Edward J Director M-Exempt D Restricted Stock Units (RSU) 75,000 0.00 0
2024-06-08 Allen David R Director M-Exempt D Restricted Stock Units (RSU) 75,000 0.00 0
2024-06-06 Tucker Kathleen Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000
2024-06-06 Selhub Eva M.D. Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000
2024-06-06 Gildea Edward J Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000
2024-06-06 Allen David R Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000
2024-04-29 Shaw Timothy Officer S-Sale D Common stock 40,205 0.26 10.3K 8,547,978
2024-04-29 Levine Jon R Director / Officer S-Sale D Common stock 50,031 0.26 12.8K 20,317,878
2024-04-27 Shaw Timothy Officer M-Exempt A Common stock 111,111 0.00 8,588,183
2024-04-27 Levine Jon R Director / Officer M-Exempt A Common stock 138,889 0.00 20,367,909
2024-04-02 Shaw Timothy Officer A-Award A Restricted Stock Units (RSU) 59,895 0.00 59,895
2024-04-02 Levine Jon R Director / Officer A-Award A Restricted Stock Units (RSU) 69,110 0.00 69,110
2024-03-07 Shaw Timothy Officer S-Sale D Common stock 15,348 0.23 3.6K 8,477,072
2024-03-07 Levine Jon R Director / Officer M-Exempt D Restricted Stock Units (RSU) 46,667 0.00 93,333
2023-11-07 Levine Jon R Director / Officer / 10% Owner A-Award A Restricted Stock Units (RSU) 450,000 0.00 450,000
2023-10-27 Shaw Timothy Officer M-Exempt A Common stock 111,111 0.00 8,482,359
2023-10-27 Levine Jon R Director / Officer / 10% Owner M-Exempt A Common stock 138,889 0.00 20,240,472
2023-09-01 Shaw Timothy Officer A-Award A Restricted Stock Units (RSU) 390,000 0.00 390,000
2023-06-08 Tucker Kathleen Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000
2023-06-08 Selhub Eva M.D. Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000
2023-06-08 Gildea Edward J Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000
2023-06-08 Allen David R Director A-Award A Restricted Stock Units (RSU) 75,000 0.00 75,000
2023-04-28 Shaw Timothy Officer S-Sale D Common stock 39,371 0.37 14.5K 8,371,248
2023-04-28 Levine Jon R Director / Officer / 10% Owner S-Sale D Common stock 49,393 0.38 18.6K 20,101,583
2023-04-27 Shaw Timothy Officer M-Exempt D Restricted Stock Units (RSU) 111,111 0.00 555,556
2023-04-27 Selhub Eva M.D. Director M-Exempt A Restricted Stock Units (RSU) 33,333 0.00 0
2023-04-27 Levine Jon R Director / Officer / 10% Owner M-Exempt D Restricted Stock Units (RSU) 138,889 0.00 694,444
2023-04-27 Gildea Edward J Director M-Exempt A Common stock 33,333 0.00 262,724
2023-04-27 Allen David R Director M-Exempt A Restricted Stock Units (RSU) 33,333 0.00 0
2023-04-17 Tucker Kathleen Director D Common stock 0 0.00 200,000
2023-03-07 Villare Susan M. Officer A-Award A Restricted Stock Units (RSU) 60,000 0.00 60,000
2023-03-07 Shaw Timothy Officer A-Award A Restricted Stock Units (RSU) 130,000 0.00 130,000
2023-03-07 Levine Jon R Director / Officer / 10% Owner A-Award A Restricted Stock Units (RSU) 140,000 0.00 140,000
2022-10-27 Shaw Timothy Officer A-Award A Restricted Stock Units (RSU) 666,667 0.00 666,667
2022-10-27 Selhub Eva M.D. Director A-Award A Restricted Stock Units (RSU) 33,333 0.00 33,333
2022-10-27 Levine Jon R Officer A-Award A Restricted Stock Units (RSU) 833,333 0.00 833,333
2022-10-27 Gildea Edward J Director A-Award A Restricted Stock Units (RSU) 33,333 0.00 33,333
2022-10-27 Fireman Robert N Officer A-Award A Restricted Stock Units (RSU) 833,333 0.00 833,333
2022-10-27 Allen David R Director A-Award A Restricted Stock Units (RSU) 33,333 0.00 33,333
2022-05-12 Villare Susan M. Officer D Common Stock 0 0.00 350,000
2021-12-28 Levine Jon R Director / Officer F-InKind D Common stock 76,226 0.86 65.6K 20,012,117
2021-12-28 Fireman Robert N Director / Officer M-Exempt A Common stock 100,000 0.63 63.0K 23,655,218
2021-10-01 Shaw Timothy Officer A-Award A Option to buy common stock 1,250,000 0.90 1.12M 1,250,000
2021-10-01 Levine Jon R Director / Officer A-Award A Option to buy common stock 5,000,000 0.90 4.49M 5,000,000
2021-10-01 Fireman Robert N Director / Officer A-Award A Option to buy common stock 5,000,000 0.90 4.49M 5,000,000
2021-07-09 Shaw Timothy Officer D Common Stock 0 0.00 7,849,508
2021-07-09 Selhub Eva M.D. Director A-Award A Option to buy common stock 100,000 0.88 88.0K 100,000
2021-07-09 Levine Jon R Director / Officer A-Award A Option to buy common stock 5,000,000 0.88 4.40M 5,000,000
2021-07-09 Gildea Edward J Director A-Award A Option to buy common stock 100,000 0.88 88.0K 100,000
2021-07-09 Fireman Robert N Director / Officer A-Award A Option to buy common stock 5,000,000 0.88 4.40M 5,000,000
2021-07-09 Allen David R Director A-Award A Option to buy common stock 100,000 0.88 88.0K 100,000
2020-12-11 Gildea Edward J Director M-Exempt D Option to buy common stock 100,000 0.14 14.0K 0
2020-11-17 Levine Jon R Director / Officer / 10% Owner M-Exempt D Option to buy common stock 350,000 0.14 49.0K 0
2020-11-17 Fireman Robert N Director / Officer / 10% Owner M-Exempt A Common stock 100,000 0.14 14.0K 23,555,218
2019-12-04 Fireman Robert N Director / Officer / 10% Owner M-Exempt A Common stock 100,000 0.14 14.0K 23,455,218
2019-09-27 Selhub Eva M.D. Director A-Award A Option to buy common stock 100,000 0.99 99.2K 100,000
2019-09-27 Gildea Edward J Director A-Award A Option to buy common stock 100,000 0.99 99.2K 100,000
2019-09-27 Allen David R Director A-Award A Option to buy common stock 100,000 0.99 99.2K 100,000
2019-09-26 Selhub Eva M.D. Director 0 0.00 0
2019-06-25 Allen David R Director 0 0.00 0
2019-05-02 KIDRIN THOMAS Director S-Sale D Common stock 30,000 3.01 90.3K 6,073,673
2019-05-01 KIDRIN THOMAS Director S-Sale D Common stock 30,000 3.20 96.0K 6,143,673
2019-01-28 Gildea Edward J Director M-Exempt D Option to buy common stock 100,000 0.08 8.0K 0
2019-01-10 Gildea Edward J Director M-Exempt A Common stock 100,000 0.08 8.0K 250,000
2018-06-15 KIDRIN THOMAS Director S-Sale D Common Stock 32,994 3.56 117.5K 1,763,673
2018-02-01 KIDRIN THOMAS Director S-Sale D Common Stock 50,000 1.08 54.0K 1,796,667
2018-01-31 KIDRIN THOMAS Director S-Sale D Common Stock 150,000 1.30 195.0K 1,846,667
2018-01-30 KIDRIN THOMAS Director S-Sale D Common Stock 100,000 1.16 116.0K 1,996,667
2018-01-02 Gildea Edward J Director A-Award A Option to buy common stock 100,000 0.63 63.0K 100,000
2017-06-30 Levine Jon R Director / Officer / 10% Owner P-Purchase A Common stock 14,807,500 3,702,000.00 54.82T 19,635,343
2017-06-30 Fireman Robert N Director / Officer / 10% Owner P-Purchase A Common stock 16,425,000 4,106,000.00 67.44T 23,255,218
2017-01-27 WORLDS INC Other D COMMON STOCK, PAR VALUE $0.010 0 0.00 5,936,115
2017-01-01 Levine Jon R Director / Officer / 10% Owner A-Award A Option to buy common stock 100,000 0.63 63.0K 100,000
2017-01-01 Fireman Robert N Director / Officer / 10% Owner A-Award A Option to buy common stock 100,000 0.63 63.0K 100,000
2016-01-01 Levine Jon R Director / Officer / 10% Owner A-Award A Option to buy common stock 350,000 0.14 49.0K 350,000
2016-01-01 Fireman Robert N Director / Officer / 10% Owner A-Award A Option to buy common stock 100,000 0.14 14.0K 100,000
2015-06-30 Gildea Edward J Director A-Award A Options 100,000 0.13 13.0K 100,000
2015-06-30 Fireman Robert N Director / Officer / 10% Owner A-Award A Option to buy common stock 100,000 0.13 13.0K 100,000
2014-09-29 Levine Jon R 10% Owner I Common Stock 0 0.00 1,997,140
2014-09-29 Fireman Robert N Director / Officer / 10% Owner P-Purchase A Common stock 6,830,218 1,229,000.00 8.39T 6,830,218
2014-01-29 Gildea Edward J Director A-Award A Options 150,000 0.08 12.0K 150,000
2014-01-10 Gildea Edward J Director 0 0.00 0
2014-01-02 Fireman Robert N Director / Officer / 10% Owner A-Award A Option to buy common stock 100,000 0.08 8.0K 100,000
2012-03-30 coleman jay Director D OPTION 0 0.57 0
2012-03-30 Fireman Robert N Director D OPTION 0 0.57 0
2011-08-10 Worlds.com, Inc. Director / Officer / 10% Owner D COMMON STOCK, PAR VALUE $0.001 0 0.00 430,000
2011-08-10 Ryan Christopher John Officer D COMMON STOCK, PAR VALUE $0.001 0 0.00 183,728
2011-05-16 Worlds.com, Inc. Director / Officer / 10% Owner D OPTION 5,000,000 0.57 2.85M 0

Executive team

Top executives
EBIT / Employee
-2.9K
Shares Outstanding
398.92M

Executive compensation

Executive compensation (annual)
# Year Executive Salary Bonus Stock award Option award Incentive Other Total % Stock-
based
Filing
1 2025 Jon R. Levine Chief Executive Officer and President 300.0K 26.1K 22.8K 349.0K 7.49%
2 2025 Ryan Crandall 300.0K 18.3K 29.4K 347.7K 5.26%
3 2025 Timothy Shaw Chief Operating Officer 325.0K 18.2K 2.8K 346.0K 5.25%
4 2024 Jon R. Levine Chief Executive Officer and President 375.0K 8.6K 57.8K 21.8K 463.2K 12.48%
5 2024 Jon R. Levine Chief Executive Officer and President 375.0K 8.6K 57.8K 21.8K 463.2K 12.48%
6 2024 Timothy Shaw Chief Operating Officer 325.0K 7.5K 50.1K 21.8K 404.4K 12.39%
7 2024 Timothy Shaw Chief Operating Officer 325.0K 7.5K 50.1K 21.8K 404.4K 12.39%
8 2024 Mario Pinho Chief Financial Officer 122.3K 48.9K 6.2K 177.4K 27.56%
9 2023 Jon R. Levine Chief Executive Officer, President and Interim Chief Financial Officer 369.7K 212.1K 20.8K 602.6K 35.19%
10 2023 Jon R. Levine Chief Executive Officer and President 369.7K 212.1K 20.8K 602.6K 35.19%
11 2023 Timothy Shaw Chief Operating Officer 323.9K 226.5K 22.7K 573.1K 39.52%
12 2023 Susan M. Villare Former Chief Financial Officer 256.7K 63.8K 28.8K 40.7K 390.0K 7.39%
13 2022 Robert Fireman Former Chief Executive Officer 336.5K 140.0K 441.7K 8.9K 927.1K 47.64%
14 2022 Jon R. Levine Chief Executive Officer and President 325.0K 130.0K 441.7K 26.7K 923.4K 47.83%
15 2022 Jon R. Levine Chief Executive Officer, President and Interim Chief Financial Officer 325.0K 130.0K 441.7K 26.7K 923.4K 47.83%
16 2022 Timothy Shaw Chief Operating Officer 300.0K 120.0K 353.3K 25.9K 799.2K 44.21%
17 2022 Susan M. Villare Former Chief Financial Officer 186.3K 217.0K 155.4K 10.4K 569.1K 65.42%
18 2022 Susan M. Villare Chief Financial Officer 186.3K 217.0K 155.4K 10.4K 569.1K 65.42%
19 2021 Jon R. Levine Chief Executive Officer and President 238.0K 23.0K 6.25M 23.0K 6.54M 96.01%
20 2021 Robert Fireman Former Chief Executive Officer 250.2K 23.0K 6.25M 4.4K 6.53M 96.10%
21 2021 Robert Fireman Chief Executive Officer 250.2K 23.0K 6.25M 6.53M 96.17%
22 2021 Jon R. Levine President 238.0K 23.0K 6.25M 6.51M 96.35%
23 2021 Timothy Shaw Chief Operating Officer 223.3K 1.56M 22.1K 1.81M 86.43%
24 2020 Timothy Shaw Chief Operating Officer 158.1K 1.8K 6.0K 165.9K 3.60%
25 2020 Jon R. Levine President 37.8K 37.5K 0.00%
26 2020 Jon R. Levine CFO 37.8K 37.5K 0.00%
27 2020 Robert Fireman President and CEO 31.8K 31.5K 0.00%
28 2020 Robert Fireman Chief Executive Officer 31.8K 31.5K 0.00%
29 2019 Robert Fireman President and CEO 150.0K 150.0K 0.00%
30 2019 Jon R. Levine CFO 150.0K 150.0K 0.00%
31 2018 Jon R. Levine CFO 10.0K 86.4K 96.4K 89.62%
32 2018 Robert Fireman President and CEO 10.0K 70.2K 80.2K 87.53%
CEO compensation breakdown

Proxy statements

Proxy statements (DEF 14A)
Filing date Form type Filing
2026-04-23 DEF 14A
2025-04-30 DEF 14A

Recent SEC filings

Recent SEC filings
Filing date Form type Filing
2026-05-08 4
2026-04-23 DEF 14A
2026-04-23 ARS
2026-04-17 4
2026-04-17 4
2026-04-17 4
2026-04-17 4
2026-04-03 4
2026-04-03 4
2026-03-30 4

Executive team

NameTitleCompensationGender
Ryan Crandall Chief Commercial Officer 440.1K male
Timothy Shaw Chief Operating Officer 327.8K male
Jon R. Levine Co-Founder, Chief Executive Officer, President, Secretary, Treasurer & Director 322.8K male
Mario Pinho Chief Financial Officer 299.8K male
Marlo Richard Vice President of Human Resources female
Charles Holt Finnie Chief Strategy Officer male
Howard Schacter Chief Communications Officer male
ESG Rating
B
DRUG MANUFACTURERS - SPECIALTY & GENERIC
2023
E (Environmental)
78.5 / 66.0
Company / Sector avg.
S (Social)
79.0 / 70.0
Company / Sector avg.
G (Governance)
69.3 / 66.6
Company / Sector avg.
ESG Total
75.6 / 67.5
Company / Sector avg.
ESG Score History DRUG MANUFACTURERS - SPECIALTY & GENERIC
Benchmark vs Sector
Senate Trading Activity

No Senate trading activity found for this company.

House Trading Activity

No House trading activity found for this company.

Market share among peers
Peer comparison — filtered group (TTM)
Your opinion

Share your view on this stock and instantly see how the community has voted over the last 6 months.

These are community opinions and do not constitute buy or sell advice to act on. The results shown are based on aggregated opinions and are not an investment recommendation, nor do they intend to influence any investment decision.

Dividend history

Earnings history

Earnings reports

Stock splits